Through a combination of fluorescence microscopy and patch-clamp analysis we have identified a striking alteration in K+ channel expression in terminally differentiated human CCR7–CD45RA– effector memory T lymphocytes (TEM). Following activation, TEM cells expressed significantly higher levels of the voltage-gated K+ channel Kv1.3 and lower levels of the calcium-activated K+ channel IKCa1 than naive and central memory T cells (TCM). Upon repeated in vitro antigenic stimulation, naive cells differentiated into Kv1.3highIKCa1low TEM cells, and the potent Kv1.3-blocking sea anemone Stichodactyla helianthus peptide (ShK) suppressed proliferation of TEM cells without affecting naive or TCM lymphocytes. Thus, the Kv1.3highIKCa1low phenotype is a functional marker of activated TEM lymphocytes. Activated myelin-reactive T cells from patients with MS exhibited the Kv1.3highIKCa1low TEM phenotype, suggesting that they have undergone repeated stimulation during the course of disease; these cells may contribute to disease pathogenesis due to their ability to home to inflamed tissues and exhibit immediate effector function. The Kv1.3highIKCa1low phenotype was not seen in glutamic acid decarboxylase, insulin-peptide or ovalbumin-specific and mitogen-activated T cells from MS patients, or in myelin-specific T cells from healthy controls. Selective targeting of Kv1.3 in TEM cells may therefore hold therapeutic promise for MS and other T cell–mediated autoimmune diseases.
Heike Wulff, Peter A. Calabresi, Rameeza Allie, Sung Yun, Michael Pennington, Christine Beeton, K. George Chandy
Title and authors | Publication | Year |
---|---|---|
Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells
Kour D, Bowen CA, Srivastava U, Nguyen HM, Kumari R, Kumar P, Brandelli AD, Bitarafan S, Tobin BR, Wood L, Seyfried NT, Wulff H, Rangaraju S |
bioRxiv | 2025 |
Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis.
Lintermans LL, Stegeman CA, Muñoz-Elías EJ, Tarcha EJ, Iadonato SP, Rutgers A, Heeringa P, Abdulahad WH |
Rheumatology (Oxford, England) | 2024 |
Activity of Potassium Channels in CD8(+) T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer?
Jusztus V, Medyouni G, Bagosi A, Lampé R, Panyi G, Matolay O, Maka E, Krasznai ZT, Vörös O, Hajdu P |
International journal of molecular sciences | 2024 |
Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysis
Kozlowska J, Humphryes-Kirilov N, Pavlovets A, Connolly M, Kuncheva Z, Horner J, Manso AS, Murray C, Fox JC, McCarthy A |
Scientific Reports | 2024 |
3,3′,4,4′-tetrachlorobiphenyl (PCB77) enhances human Kv1.3 channel currents and alters cytokine production
Kim JH, Hwang S, Park SI, Lee HJ, Jung YJ, Jo SH |
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology | 2024 |
Effect of Voltage-Gated K+ Channel Inhibition by 4-aminopyridine in Spinal Cord Injury Recovery in Zebrafish
Hoffman PM, Mruk K |
2024 | |
Immunomodulatory effect of Tityus sp. in mononuclear cells extracted from the blood of rheumatoid arthritis patients.
Tobar CGR, Urmendiz YDMM, Vallejo MA, Manquillo DF, Castaño VEN, Caicedo AIO, Tobar LLM, Vargas JAG, Cuellar RAD |
The journal of venomous animals and toxins including tropical diseases | 2024 |
Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19
Ameet Chimote, Abdulaziz Alshwimi, Martina Chirra, Vaibhavkumar Gawali, Margaret Powers-Fletcher, Kristin Hudock, Laura Conforti |
Frontiers in immunology | 2023 |
Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K(+) Channel K(V)1.2 and Small- and Intermediate-Conductance Ca(2+)-Activated K(+) Channels K(Ca)2.2 and K(Ca)3.1.
Naseem MU, Gurrola-Briones G, Romero-Imbachi MR, Borrego J, Carcamo-Noriega E, Beltrán-Vidal J, Zamudio FZ, Shakeel K, Possani LD, Panyi G |
Toxins | 2023 |
A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
Wang Y, Zhu D, Ortiz-Velez LC, Perry JL, Pennington MW, Hyser JM, Britton RA, Beeton C |
Proceedings of the National Academy of Sciences | 2023 |
The immunosuppressive effects and mechanisms of loureirin B on collagen-induced arthritis in rats
Zou Y, Zhao Q, Zhang X, Yu H, Zhou Y, Li Z, Xiao M, Xiang Q, Zhang L, Shi W, Tao H, Chen L, Han B, Yin S |
Frontiers in immunology | 2023 |
Inhibitory effects of N-methyl-D-aspartate (NMDA) and α(1)-adrenergic receptor antagonist ifenprodil on human Kv1.5 channel.
Hwang S, Yoon B, Jo SH |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2023 |
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human H(V)1 Channel.
Szanto TG, Feher A, Korpos E, Gyöngyösi A, Kállai J, Mészáros B, Ovari K, Lányi Á, Panyi G, Varga Z |
Pharmaceuticals (Basel, Switzerland) | 2023 |
Neural Regeneration in Dry Eye Secondary to Systemic Lupus Erythematosus Is Also Disrupted like in Rheumatoid Arthritis, but in a Progressive Fashion
Sonkodi B, Marsovszky L, Csorba A, Balog A, Kopper B, Nagy ZZ, Resch MD |
International journal of molecular sciences | 2023 |
Reduction of Ca(2+) Entry by a Specific Block of KCa3.1 Channels Optimizes Cytotoxic Activity of NK Cells against T-ALL Jurkat Cells.
Olivas-Aguirre M, Cruz-Aguilar LH, Pottosin I, Dobrovinskaya O |
Cells | 2023 |
Structure of the voltage-gated potassium channel K(V)1.3: Insights into the inactivated conformation and binding to therapeutic leads.
Chandy KG, Sanches K, Norton RS |
Channels (Austin, Tex.) | 2023 |
Dynamics and spatial organization of Kv1.3 at the immunological synapse of human CD4+ T cells
Capera J, Jainarayanan A, Navarro-Pérez M, Valvo S, Demetriou P, Depoil D, Estadella I, Kvalvaag A, Felce JH, Felipe A, Dustin ML |
Biophysical Journal | 2023 |
Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases
C Cañas, S Castaño-Valencia, F Castro-Herrera |
2022 | |
Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response
J Goggi, S Khanapur, B Ramasamy, S Hartimath, T Rong, P Cheng, Y Tan, X Yeo, S Jung, S Goay, S Ong, Y Hwang, K Chandy, E Robins |
Cancers | 2022 |
Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.
Naseem MU, Carcamo-Noriega E, Beltrán-Vidal J, Borrego J, Szanto TG, Zamudio FZ, Delgado-Prudencio G, Possani LD, Panyi G |
The Journal of General Physiology | 2022 |
Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators.
Selvakumar P, Fernández-Mariño AI, Khanra N, He C, Paquette AJ, Wang B, Huang R, Smider VV, Rice WJ, Swartz KJ, Meyerson JR |
Nature Communications | 2022 |
Centipede Venom: A Potential Source of Ion Channel Modulators.
Luo A, Wang A, Kamau PM, Lai R, Luo L |
International journal of molecular sciences | 2022 |
How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.
Chirra M, Newton HS, Gawali VS, Wise-Draper TM, Chimote AA, Conforti L |
Cancers | 2022 |
Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle!
Schlöder J, Shahneh F, Schneider FJ, Wieschendorf B |
Frontiers in immunology | 2022 |
Neurotoxins and pore forming toxins in sea anemones: Potential candidates for new drug development.
Wang ZL, Zhang SY, Hao SL, Yang WX |
Histology and histopathology | 2022 |
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
V Hofschröer, K Najder, M Rugi, R Bouazzi, M Cozzolino, A Arcangeli, G Panyi, A Schwab |
Frontiers in pharmacology | 2021 |
Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
I Markakis, I Charitakis, C Beeton, M Galani, E Repousi, S Aggeloglou, PP Sfikakis, MW Pennington, KG Chandy, C Poulopoulou |
Frontiers in pharmacology | 2021 |
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
M Olivas-Aguirre, L Torres-López, I Pottosin, O Dobrovinskaya |
Frontiers in Oncology | 2021 |
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
R Hirawat, MA Saifi, C Godugu |
Life Sciences | 2021 |
The voltage-gated potassium channel KV1.3 regulates neutrophil recruitment during inflammation
R Immler, W Nadolni, A Bertsch, V Morikis, I Rohwedder, S Masgrau-Alsina, T Schroll, A Yevtushenko, O Soehnlein, M Moser, T Gudermann, ER Barnea, M Rehberg, SI Simon, S Zierler, M Pruenster, M Sperandio |
Cardiovascular Research | 2021 |
Immunological Responses to Envenomation
RY Ryan, J Seymour, A Loukas, JA Lopez, MP Ikonomopoulou, JJ Miles |
Frontiers in immunology | 2021 |
Neuroprotective Properties of 4-Aminopyridine
M Dietrich, HP Hartung, P Albrecht |
Neurology: Neuroimmunology & Neuroinflammation | 2021 |
Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
DK Singh, S Tousif, A Bhaskar, A Devi, K Negi, B Moitra, A Ranganathan, VP Dwivedi, G Das, HI Boshoff |
PLoS pathogens | 2021 |
Optimization of Pichia pastoris Expression System for High-Level Production of Margatoxin.
Naseem MU, Tajti G, Gaspar A, Szanto TG, Borrego J, Panyi G |
Frontiers in pharmacology | 2021 |
Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.
Gubič Š, Hendrickx LA, Toplak Ž, Sterle M, Peigneur S, Tomašič T, Pardo LA, Tytgat J, Zega A, Mašič LP |
Medicinal Research Reviews | 2021 |
Pharmacological Approaches to Studying Potassium Channels.
Mathie A, Veale EL, Golluscio A, Holden RG, Walsh Y |
Handbook of experimental pharmacology | 2021 |
The role of the voltage-gated potassium channel, Kv2.1 in prostate cancer cell migration
Park HW, Song MS, Sim HJ, Ryu PD, Lee SY |
BMB Reports | 2021 |
Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
DK Singh, VP Dwivedi, SP Singh, A Kumari, SK Sharma, A Ranganathan, LV Kaer, G Das, DM Lewinsohn |
PLoS pathogens | 2020 |
Altered Ca2+ Homeostasis in Immune Cells during Aging: Role of Ion Channels
D Zöphel, C Hof, A Lis |
International journal of molecular sciences | 2020 |
Modulation of Lymphocyte Potassium Channel K V 1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin
ST Ong, S Bajaj, MR Tanner, SC Chang, B Krishnarjuna, XR Ng, RA Morales, MW Chen, D Luo, D Patel, S Yasmin, JJ Ng, Z Zhuang, HM Nguyen, AE Sahili, J Lescar, R Patil, SA Charman, EG Robins, JL Goggi, PW Tan, P Sadasivam, B Ramasamy, SV Hartimath, V Dhawan, J Bednenko, P Colussi, H Wulff, MW Pennington, S Kuyucak, RS Norton, C Beeton, KG Chandy |
2020 | |
Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
X Wang, G Li, J Guo, Z Zhang, S Zhang, Y Zhu, J Cheng, L Yu, Y Ji, J Tao |
Frontiers in neuroscience | 2020 |
Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes
WT Chang, PY Liu, SN Wu |
Molecules (Basel, Switzerland) | 2020 |
Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.
Papp F, Hajdu P, Tajti G, Toth A, Nagy E, Fazekas Z, Kovacs S, Vámosi G, Varga Z, Panyi G |
International journal of molecular sciences | 2020 |
Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1
CJ Mohr, FA Steudel, D Gross, P Ruth, WY Lo, R Hoppe, W Schroth, H Brauch, SM Huber, R Lukowski |
Cancers | 2019 |
Critical regulation of atherosclerosis by the KCa3.1 channel and the retargeting of this therapeutic target in in-stent neoatherosclerosis
YR Zhu, XX Jiang, DM Zhang |
Journal of Molecular Medicine | 2019 |
Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression
IS Oliveira, IG Ferreira, GM Alexandre-Silva, FA Cerni, CM Cremonez, EC Arantes, U Zottich, MB Pucca |
Journal of Venomous Animals and Toxins | 2019 |
KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
MR Tanner, MW Pennington, SS Chauhan, T Laragione, PS Gulko, C Beeton |
Arthritis Research & Therapy | 2019 |
Centipede KCNQ Inhibitor SsTx Also Targets KV1.3
C Du, J Li, Z Shao, J Mwangi, R Xu, H Tian, G Mo, R Lai, S Yang |
Toxins | 2019 |
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
E Hortle, L Starrs, F Brown, S Jane, D Curtis, BJ McMorran, SJ Foote, G Burgio |
Scientific Reports | 2019 |
Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
S Ahmad, D Bhattacharya, S Kar, A Ranganathan, LV Kaer, G Das, S Ehrt |
Infection and immunity | 2019 |
Conformational exchange in the potassium channel blocker ShK.
Iwakawa N, Baxter NJ, Wai DCC, Fowler NJ, Morales RAV, Sugase K, Norton RS, Williamson MP |
Scientific Reports | 2019 |
Extracellular K+ Dampens T Cell Functions: Implications for Immune Suppression in the Tumor Microenvironment
Ong ST, Ng AS, Ng XR, Zhuang Z, Wong BH, Prasannan P, Kok YJ, Bi X, Shim H, Wulff H, Chandy KG, Verma NK |
2019 | |
Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles
A Zakeri, EP Hansen, SD Andersen, AR Williams, P Nejsum |
Frontiers in immunology | 2018 |
Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels
P Severino, A DAmato, L Netti, M Pucci, MD Marchis, R Palmirotta, M Volterrani, M Mancone, F Fedele |
International journal of molecular sciences | 2018 |
A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3
J Bednenko, R Harriman, L Mariën, HM Nguyen, A Agrawal, A Papoyan, Y Bisharyan, J Cardarelli, D Cassidy-Hanley, T Clark, D Pedersen, Y Abdiche, W Harriman, B van der Woning, H de Haard, E Collarini, H Wulff, P Colussi |
mAbs | 2018 |
A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis
XL Yuan, YP Zhao, J Huang, JC Liu, WQ Mao, J Yin, BW Peng, WH Liu, S Han, XH He |
CNS Neuroscience & Therapeutics | 2018 |
Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma
A Grimaldi, G DAlessandro, MA di Castro, C Lauro, V Singh, F Pagani, L Sforna, F Grassi, SD Angelantonio, L Catacuzzeno, H Wulff, C Limatola, M Catalano |
Scientific Reports | 2018 |
Kv1.3 channel blockade with the Vm24 scorpion toxin attenuates the CD4+ effector memory T cell response to TCR stimulation
JI Veytia-Bucheli, JM Jiménez-Vargas, EI Melchy-Pérez, MA Sandoval-Hernández, LD Possani, Y Rosenstein |
Cell Communication and Signaling | 2018 |
Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients
GM Diaz, J Fraussen, BV Wijmeersch, R Hupperts, V Somers |
Scientific Reports | 2018 |
Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis
I Bozic, K Tesovic, D Laketa, M Adzic, M Jakovljevic, I Bjelobaba, D Savic, N Nedeljkovic, S Pekovic, I Lavrnja |
Neurochemical Research | 2018 |
Differential Activity of Voltage- and Ca2+-Dependent Potassium Channels in Leukemic T Cell Lines: Jurkat Cells Represent an Exceptional Case
S Valle-Reyes, G Valencia-Cruz, L Liñan-Rico, I Pottosin, O Dobrovinskaya |
Frontiers in physiology | 2018 |
The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo
JD Lucente, HM Nguyen, H Wulff, LW Jin, I Maezawa |
Glia | 2018 |
Differences in ion channel phenotype and function between humans and animal models.
Tanner MR, Beeton C |
2018 | |
Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept
I Maezawa, HM Nguyen, JD Lucente, DP Jenkins, V Singh, S Hilt, K Kim, S Rangaraju, AI Levey, H Wulff, LW Jin |
Brain | 2017 |
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog
MR Tanner, RB Tajhya, R Huq, EJ Gehrmann, KE Rodarte, MA Atik, RS Norton, MW Pennington, C Beeton |
Clinical Immunology | 2017 |
GABA A receptor α 4 -subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model
GT Yocum, DL Turner, J Danielsson, MB Barajas, Y Zhang, D Xu, NL Harrison, GE Homanics, DL Farber, CW Emala |
American journal of physiology. Lung cellular and molecular physiology | 2017 |
T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers
WP Fung-Leung, W Edwards, Y Liu, K Ngo, J Angsana, G Castro, N Wu, X Liu, RV Swanson, AD Wickenden, TA Baldwin |
PloS one | 2017 |
Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
EY Chiang, T Li, S Jeet, I Peng, J Zhang, WP Lee, J DeVoss, P Caplazi, J Chen, S Warming, DH Hackos, S Mukund, CM Koth, JL Grogan |
Nature Communications | 2017 |
Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit
T Kubota, AM Correa, F Bezanilla |
Scientific Reports | 2017 |
Helminth Immunomodulation in Autoimmune Disease
JJ Miles, TB Smallwood, PR Giacomin, A Loukas, JP Mulvenna, RJ Clark |
Frontiers in immunology | 2017 |
Direct Binding of the pH-Regulated Protein 1 (Pra1) from Candida albicans Inhibits Cytokine Secretion by Mouse CD4+ T Cells
A Bergfeld, P Dasari, S Werner, TR Hughes, WC Song, P Hortschansky, AA Brakhage, T Hünig, PF Zipfel, N Beyersdorf |
Frontiers in microbiology | 2017 |
Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis
J Huang, S Han, Q Sun, Y Zhao, J Liu, X Yuan, W Mao, B Peng, W Liu, J Yin, X He |
Cell & Bioscience | 2017 |
A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation
S Rangaraju, SA Raza, A Pennati, Q Deng, EB Dammer, D Duong, MW Pennington, MG Tansey, JJ Lah, R Betarbet, NT Seyfried, AI Levey |
Journal of Neuroinflammation | 2017 |
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
EJ Tarcha, CM Olsen, P Probst, D Peckham, EJ Muñoz-Elías, JG Kruger, SP Iadonato, H Wiendl |
PloS one | 2017 |
Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8+ T Cells
JH Sim, KS Kim, H Park, KJ Kim, H Lin, TJ Kim, HM Shin, G Kim, DS Lee, CW Park, DH Lee, I Kang, SJ Kim, CH Cho, J Doh, HR Kim |
Frontiers in immunology | 2017 |
Niche-specific gene expression in a parasitic nematode; increased expression of immunomodulators in Teladorsagia circumcincta larvae derived from host mucosa
TN McNeilly, D Frew, ST Burgess, H Wright, DJ Bartley, Y Bartley, AJ Nisbet |
Scientific Reports | 2017 |
T-lymphocyte Kv1.3 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients
J Zhu, Y Yang, SG Hu, QB Zhang, J Yu, YM Zhang |
Experimental and therapeutic medicine | 2017 |
KCa1.1 channels as therapeutic targets for rheumatoid arthritis
C Beeton |
Expert Opinion on Therapeutic Targets | 2017 |
Cloning, expression and identification of KTX-Sp4, a selective Kv1.3 peptidic blocker from Scorpiops pococki
Y Zou, F Zhang, Y Li, Y Wang, Y Li, Z Long, S Shi, L Shuai, J Liu, Z Di, S Yin |
Cell & Bioscience | 2017 |
Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
YJ Chen, HM Nguyen, I Maezawa, LW Jin, H Wulff |
Annals of Clinical and Translational Neurology | 2017 |
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
RE Wang, Y Wang, Y Zhang, C Gabrelow, Y Zhang, V Chi, Q Fu, X Luo, D Wang, S Joseph, K Johnson, AK Chatterjee, TM Wright, VT Nguyen-Tran, J Teijaro, AN Theofilopoulos, PG Schultz, F Wang |
Proceedings of the National Academy of Sciences | 2016 |
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness
T Lowinus, T Bose, S Busse, M Busse, D Reinhold, B Schraven, UH Bommhardt |
Oncotarget | 2016 |
The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke
YJ Chen, HM Nguyen, I Maezawa, EM Grössinger, AL Garing, R Köhler, LW Jin, H Wulff |
Journal of Cerebral Blood Flow & Metabolism | 2016 |
Ionic immune suppression within the tumour microenvironment limits T cell effector function
R Eil, SK Vodnala, D Clever, CA Klebanoff, M Sukumar, JH Pan, DC Palmer, A Gros, TN Yamamoto, SJ Patel, GC Guittard, Z Yu, V Carbonaro, K Okkenhaug, DS Schrump, WM Linehan, R Roychoudhuri, NP Restifo |
Nature | 2016 |
Probing pattern and dynamics of disulfide bridges using synthesis and NMR of an ion channel blocker peptide toxin with multiple diselenide bonds
K Fehér, I Timári, K Rákosi, J Szolomájer, TZ Illyés, A Bartok, Z Varga, G Panyi, GK Tóth, KE Kövér |
Chemical Science | 2016 |
The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases
F Ye, Y Hu, W Yu, Z Xie, J Hu, Z Cao, W Li, Y Wu |
Toxins | 2016 |
Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K + channel pattern in T cells
MB Pucca, TB Bertolini, FA Cerni, KC Bordon, S Peigneur, J Tytgat, VL Bonato, EC Arantes |
Immunology | 2016 |
The Role of KV7.3 in Regulating Osteoblast Maturation and Mineralization
J Yang, M Song, Y Shen, P Ryu, S Lee |
International journal of molecular sciences | 2016 |
Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes
Z Pethő, MR Tanner, RB Tajhya, R Huq, T Laragione, G Panyi, PS Gulko, C Beeton |
Arthritis Research & Therapy | 2016 |
Peptidomimetic Star Polymers for Targeting Biological Ion Channels
R Chen, D Lu, Z Xie, J Feng, Z Jia, J Ho, ML Coote, Y Wu, MJ Monteiro, SH Chung, AG Obukhov |
PloS one | 2016 |
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
R Huq, EL Samuel, WK Sikkema, LG Nilewski, T Lee, MR Tanner, FS Khan, PC Porter, RB Tajhya, RS Patel, T Inoue, RG Pautler, DB Corry, JM Tour, C Beeton |
Scientific Reports | 2016 |
Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia: Potassium Channel Expression in Microglia
HM Nguyen, EM Grössinger, M Horiuchi, KW Davis, LW Jin, I Maezawa, H Wulff |
Glia | 2016 |
Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs
I Kazama, T Tamada |
Allergy Asthma & Clinical Immunology | 2016 |
Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury
RD Fortune, RJ Grill, C Beeton, M Tanner, R Huq, DS Loose |
Journal of Neurotrauma | 2016 |
Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties
IV Grishkan, DM Tosi, MD Bowman, M Harary, PA Calabresi, AR Gocke |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Multiple Sclerosis and T Lymphocytes: An Entangled Story
L Legroux, N Arbour |
Journal of Neuroimmune Pharmacology | 2015 |
Ion Channels in Innate and Adaptive Immunity
S Feske, H Wulff, EY Skolnik |
Annual Review of Immunology | 2015 |
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling
W Li, Z Zhang, K Zhang, Z Xue, Y Li, Z Zhang, L Zhang, C Gu, Q Zhang, J Hao, Y Da, Z Yao, Y Kong, R Zhang |
Molecular Neurobiology | 2015 |
The functional contribution of calcium ion flux heterogeneity in T cells
SN Christo, KR Diener, JD Hayball |
Immunology and Cell Biology | 2015 |
N-terminally extended analogues of the K + channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3
SC Chang, R Huq, S Chhabra, C Beeton, MW Pennington, BJ Smith, RS Norton |
FEBS Journal | 2015 |
Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca2+ channels
RV Frolov, S Singh |
BMC Research Notes | 2015 |
Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
M Pennington, S Chang, S Chauhan, R Huq, R Tajhya, S Chhabra, R Norton, C Beeton |
Marine drugs | 2015 |
Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner
J Yu, MH Park, SY Choi, SH Jo |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2015 |
Placing Ion Channels into a Signaling Network of T Cells: From Maturing Thymocytes to Healthy T Lymphocytes or Leukemic T Lymphoblasts
O Dobrovinskaya, I Delgado-Enciso, LJ Quintero-Castro, C Best-Aguilera, RM Rojas-Sotelo, I Pottosin |
BioMed Research International | 2015 |
Novel therapies for memory cells in autoimmune diseases: Novel therapies for memory cells
P Bhargava, PA Calabresi |
Clinical & Experimental Immunology | 2015 |
The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin
P Hajdu, GV Martin, AA Chimote, O Szilagyi, K Takimoto, L Conforti |
Molecular biology of the cell | 2015 |
Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel
Z Chen, Y Hu, J Hong, J Hu, W Yang, F Xiang, F Yang, Z Xie, Z Cao, W Li, D Lin, Y Wu |
Scientific Reports | 2015 |
Kv1.3 contains an alternative C-terminal ER exit motif and is recruited into COPII vesicles by Sec24a
JM Spear, DA Koborssy, AB Schwartz, AJ Johnson, A Audhya, DA Fadool, SM Stagg |
BMC Biochemistry | 2015 |
Toxins Targeting the KV1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
Y Zhao, J Huang, X Yuan, B Peng, W Liu, S Han, X He |
Toxins | 2015 |
Lack of effect of Z-butylidenephthalide on presynaptic N-type Ca2+ channels in isolated guinea-pig ileum
M Chen, WC Ko |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2015 |
Inhibition of Kv channel expression by NSAIDs depolarizes membrane potential and inhibits cell migration by disrupting calpain signaling
K Silver, A Littlejohn, L Thomas, E Marsh, JD Lillich |
Biochemical Pharmacology | 2015 |
An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility
A Bartok, K Fehér, A Bodor, K Rákosi, GK Tóth, KE Kövér, G Panyi, Z Varga |
Scientific Reports | 2015 |
State-dependent blocking mechanism of K v 1.3 channels by the antimycobacterial drug clofazimine: State-dependent block of Kv1.3 by clofazimine
M Faouzi, J Starkus, R Penner |
British Journal of Pharmacology | 2015 |
Mutational Consequences of Aberrant Ion Channels in Neurological Disorders
D Kumar, RK Ambasta, P Kumar |
The Journal of Membrane Biology | 2014 |
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis
LK Hansen, L Sevelsted-Møller, M Rabjerg, D Larsen, TP Hansen, L Klinge, H Wulff, T Knudsen, J Kjeldsen, R Köhler |
Journal of Crohn's and Colitis | 2014 |
Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
H Kang, A Kerloc’h, M Rotival, X Xu, Q Zhang, Z D’Souza, M Kim, JC Scholz, JH Ko, PK Srivastava, JR Genzen, W Cui, TJ Aitman, L Game, JE Melvin, A Hanidu, J Dimock, J Zheng, D Souza, AK Behera, G Nabozny, HT Cook, JH Bassett, GR Williams, J Li, A Vignery, E Petretto, J Behmoaras |
Cell Reports | 2014 |
Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells
S Yin, Q Hu, J Luo, Y Li, C Lu, X Chen, H Hu |
Cell & Bioscience | 2014 |
Ion channels and anti-cancer immunity
G Panyi, C Beeton, A Felipe |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2014 |
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
MH Rashid, R Huq, MR Tanner, S Chhabra, KK Khoo, R Estrada, V Dhawan, S Chauhan, MW Pennington, C Beeton, S Kuyucak, RS Norton |
Scientific Reports | 2014 |
Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review
RJ Bright, J Wilkinson, BJ Coventry |
BMC neurology | 2014 |
Electrophysiological Characterization of Ts6 and Ts7, K+ Channel Toxins Isolated through an Improved Tityus serrulatus Venom Purification Procedure
F Cerni, M Pucca, S Peigneur, C Cremonez, K Bordon, J Tytgat, E Arantes |
Toxins | 2014 |
Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – Xenograft model
S Kundu-Raychaudhuri, YJ Chen, H Wulff, SP Raychaudhuri |
Journal of Autoimmunity | 2014 |
Oxidative Modulation of Voltage-Gated Potassium Channels
N Sahoo, T Hoshi, SH Heinemann |
Antioxidants & Redox Signaling | 2014 |
T Cells in Vascular Inflammatory Diseases
LL Lintermans, CA Stegeman, P Heeringa, WH Abdulahad |
Frontiers in immunology | 2014 |
The CNS under pathophysiologic attack—examining the role of K2P channels
P Ehling, M Cerina, T Budde, SG Meuth, S Bittner |
Pflügers Archiv - European Journal of Physiology | 2014 |
Binding Modes of Two Scorpion Toxins to the Voltage-Gated Potassium Channel Kv1.3 Revealed from Molecular Dynamics
R Chen, SH Chung |
Toxins | 2014 |
Physiological Role of Kv1.3 Channel in T Lymphocyte Cell Investigated Quantitatively by Kinetic Modeling
P Hou, R Zhang, Y Liu, J Feng, W Wang, Y Wu, J Ding, SE Dryer |
PloS one | 2014 |
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
S Chhabra, SC Chang, HM Nguyen, R Huq, MR Tanner, LM Londono, R Estrada, V Dhawan, S Chauhan, SK Upadhyay, M Gindin, PJ Hotez, JG Valenzuela, B Mohanty, JD Swarbrick, H Wulff, SP Iadonato, GA Gutman, C Beeton, MW Pennington, RS Norton, KG Chandy |
The FASEB Journal | 2014 |
Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
S Koshy, R Huq, MR Tanner, MA Atik, PC Porter, FS Khan, MW Pennington, NA Hanania, DB Corry, C Beeton |
The Journal of biological chemistry | 2014 |
Autoimmune effector memory T cells: the bad and the good
P Devarajan, Z Chen |
Immunologic Research | 2013 |
The Potassium Channel KCa3.1 as New Therapeutic Target for the Prevention of Obliterative Airway Disease:
X Hua, T Deuse, YJ Chen, H Wulff, M Stubbendorff, R Köhler, H Miura, F Länger, H Reichenspurner, RC Robbins, S Schrepfer |
Transplantation | 2013 |
The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy
YJ Chen, J Lam, CR Gregory, S Schrepfer, H Wulff |
PloS one | 2013 |
Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF- 1/Smad Pathway in Diabetic Mice
C Huang, S Shen, Q Ma, J Chen, A Gill, CA Pollock, XM Chen |
Diabetes | 2013 |
Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes
S Koshy, D Wu, X Hu, RB Tajhya, R Huq, FS Khan, MW Pennington, H Wulff, P Yotnda, C Beeton |
PloS one | 2013 |
Potent Suppression of Kv1.3 Potassium Channel and IL-2 Secretion by Diphenyl Phosphine Oxide-1 in Human T Cells
N Zhao, Q Dong, LL Du, XX Fu, YM Du, YH Liao, X Chen |
PloS one | 2013 |
Functionalized liposomes loaded with siRNAs targeting ion channels in effector memory T cells as a potential therapy for autoimmunity
P Hajdu, AA Chimote, TH Thompson, Y Koo, Y Yun, L Conforti |
Biomaterials | 2013 |
Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation
T Wang, E Choi, MC Monaco, E Campanac, M Medynets, T Do, P Rao, KR Johnson, AG Elkahloun, GV Geldern, T Johnson, S Subramaniam, D Hoffman, E Major, A Nath, W Hu |
PloS one | 2013 |
A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
MH Rashid, G Heinzelmann, R Huq, RB Tajhya, SC Chang, S Chhabra, MW Pennington, C Beeton, RS Norton, S Kuyucak, A Cavalli |
PloS one | 2013 |
Modulation of T Lymphocyte Calcium Influx Patterns Via the Inhibition of Kv1.3 and Ikca1 Potassium Channels in Autoimmune Disorders
C Orbán, E Biró, E Grozdics, A Bajnok, G Toldi |
Frontiers in immunology | 2013 |
KCa3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma
JV der Velden, G Sum, D Barker, E Koumoundouros, G Barcham, H Wulff, N Castle, P Bradding, K Snibson, M Idzko |
PloS one | 2013 |
Expression of Kv1.3 potassium channels regulates density of cortical interneurons: Kv1.3 Regulates Cortical Interneurons
A Duque, VR Gazula, LK Kaczmarek |
Developmental Neurobiology | 2013 |
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity
J Liu, P Xu, C Collins, H Liu, J Zhang, JP Keblesh, H Xiong, ML Block |
PloS one | 2013 |
Computational Studies of Marine Toxins Targeting Ion Channels
M Rashid, S Mahdavi, S Kuyucak |
Marine drugs | 2013 |
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes
L Hu, T Wang, AR Gocke, A Nath, H Zhang, JB Margolick, KA Whartenby, PA Calabresi, JX Gao |
PloS one | 2013 |
Kv1.3 deletion biases T cells towards an immuno-regulatory phenotype and renders mice resistant to autoimmune encephalomyelitis1
AR Gocke, LA Lebson, IV Grishkan, L Hu, HM Nguyen, KA Whartenby, KG Chandy, PA Calabresi |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
The Antibody Targeting the E314 Peptide of Human Kv1.3 Pore Region Serves as a Novel, Potent and Specific Channel Blocker
XF Yang, Y Yang, YT Lian, ZH Wang, XW Li, LX Cheng, JP Liu, YF Wang, X Gao, YH Liao, M Wang, QT Zeng, K Liu, SG Meuth |
PloS one | 2012 |
Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL
Y Yang, YF Wang, XF Yang, ZH Wang, YT Lian, Y Yang, XW Li, X Gao, J Chen, YW Shu, LX Cheng, YH Liao, K Liu |
Journal of lipid research | 2012 |
Conotoxins that Confer Therapeutic Possibilities
M Essack, VB Bajic, JA Archer |
Marine drugs | 2012 |
Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
I Maezawa, DP Jenkins, BE Jin, H Wulff |
International Journal of Alzheimer's Disease | 2012 |
Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model
Z Li, WH Liu, S Han, BW Peng, J Yin, YL Wu, XH He, WX Li |
The Journal of biological chemistry | 2012 |
KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells
Z Kuras, YH Yun, AA Chimote, L Neumeier, L Conforti |
PloS one | 2012 |
Ion channels and transporters in lymphocyte function and immunity
S Feske, EY Skolnik, M Prakriya |
Nature Reviews Immunology | 2012 |
Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors
LH Wang, N Wang, XY Lu, BC Liu, MK Yanda, JZ Song, HM Dai, YL Sun, HF Bao, DC Eaton, HP Ma |
2012 | |
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria
SC Chang, CA Galea, EW Leung, RB Tajhya, C Beeton, MW Pennington, RS Norton |
Toxicon | 2012 |
Protective Roles for Potassium SK/KCa2 Channels in Microglia and Neurons
AM Dolga, C Culmsee |
Frontiers in pharmacology | 2012 |
A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3
MW Pennington, MH Rashid, RB Tajhya, C Beeton, S Kuyucak, RS Norton |
FEBS Letters | 2012 |
Modeling and Simulation of Ion Channels
C Maffeo, S Bhattacharya, J Yoo, D Wells, A Aksimentiev |
Chemical Reviews | 2012 |
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
EJ Tarcha, V Chi, EJ Munoz-Elias, D Bailey, LM Londono, SK Upadhyay, K Norton, A Banks, I Tjong, H Nguyen, X Hu, GW Ruppert, SE Boley, R Slauter, J Sams, B Knapp, D Kentala, Z Hansen, MW Pennington, C Beeton, KG Chandy, SP Iadonato |
The Journal of pharmacology and experimental therapeutics | 2012 |
Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells
Z Varga, G Gurrola-Briones, F Papp, RC de la Vega, G Pedraza-Alva, RB Tajhya, R Gaspar, L Cardenas, Y Rosenstein, C Beeton, LD Possani, G Panyi |
Molecular pharmacology | 2012 |
K+ channel alterations in the progression of experimental autoimmune encephalomyelitis
PI Jukkola, AE Lovett-Racke, SS Zamvil, C Gu |
Neurobiology of Disease | 2012 |
Modulation of T cell activation by localized K+ accumulation at the immunological synapse—A mathematical model
GV Martin, Y Yun, L Conforti |
Journal of Theoretical Biology | 2012 |
KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
X Hu, T Laragione, L Sun, S Koshy, KR Jones, II Ismailov, P Yotnda, FT Horrigan, PS Gulko, C Beeton |
The Journal of biological chemistry | 2012 |
A Human-Mouse Chimeric Model of Obliterative Bronchiolitis after Lung Transplantation
J Xue, X Zhu, MP George, MM Myerburg, MW Stoner, JW Pilewski, SR Duncan |
The American Journal of Pathology | 2011 |
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models
LT Mars, P Saikali, RS Liblau, N Arbour |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2011 |
The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression
J Lam, H Wulff |
Drug Development Research | 2011 |
Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis
CL Pittet, J Newcombe, A Prat, N Arbour |
Journal of Neuroinflammation | 2011 |
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
V Chi, MW Pennington, RS Norton, EJ Tarcha, LM Londono, B Sims-Fahey, SK Upadhyay, JT Lakey, S Iadonato, H Wulff, C Beeton, KG Chandy |
Toxicon | 2011 |
Influence of Specific Immunotherapy on the Activity of Human T Lymphocyte Kv1.3 Voltage-Gated Potassium Channels in Insect Venom Allergic Patients
M Nittner-Marszalska, A Teisseyre, B Jaźwiec, A Kowal, M Wujczyk, A Gawlik, M Krasnowska |
The Journal of Membrane Biology | 2011 |
Modeling the Binding of Three Toxins to the Voltage-Gated Potassium Channel (Kv1.3)
R Chen, A Robinson, D Gordon, SH Chung |
Biophysical Journal | 2011 |
Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21cip1 Signaling
L Hu, AR Gocke, E Knapp, JM Rosenzweig, IV Grishkan, EG Baxi, H Zhang, JB Margolick, KA Whartenby, PA Calabresi |
The Journal of biological chemistry | 2011 |
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.
Beeton C, Pennington MW, Norton RS |
Inflammation & allergy drug targets | 2011 |
Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis
L Di, S Srivastava, O Zhdanova, Y Ding, Z Li, H Wulff, M Lafaille, EY Skolnik |
Proceedings of the National Academy of Sciences | 2010 |
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840
H Wulff |
Expert Opinion on Therapeutic Patents | 2010 |
Selected MicroRNAs Define Cell Fate Determination of Murine Central Memory CD8 T Cells
G Almanza, A Fernandez, S Volinia, X Cortez-Gonzalez, CM Croce, M Zanetti, D Unutmaz |
PloS one | 2010 |
Natural products and ion channel pharmacology
RW Teichert, BM Olivera |
Future Medicinal Chemistry | 2010 |
Therapeutic potential of KCa3.1 blockers: an overview of recent advances, and promising trends
H Wulff, NA Castle |
Expert Review of Clinical Pharmacology | 2010 |
Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers
A Cheong, J Li, P Sukumar, B Kumar, F Zeng, K Riches, C Munsch, IC Wood, KE Porter, DJ Beech |
Cardiovascular Research | 2010 |
Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis
T Hyodo, T Oda, Y Kikuchi, K Higashi, T Kushiyama, K Yamamoto, M Yamada, S Suzuki, R Hokari, M Kinoshita, S Seki, H Fujinaka, T Yamamoto, S Miura, H Kumagai |
AJP Renal Physiology | 2010 |
From the Background to the Spotlight: TASK Channels in Pathological Conditions: TASK Channels in Pathology
S Bittner, T Budde, H Wiendl, SG Meuth |
Brain Pathology | 2010 |
Nucleoside Diphosphate Kinase B Knock-out Mice Have Impaired Activation of the K+ Channel KCa3.1, Resulting in Defective T Cell Activation
L Di, S Srivastava, O Zhdanova, Y Sun, Z Li, EY Skolnik |
The Journal of biological chemistry | 2010 |
Use of Kv1.3 blockers for inflammatory skin conditions.
Nguyen W, Howard BL, Neale DS, Thompson PE, White PJ, Wulff H, Manallack DT |
Current medicinal chemistry | 2010 |
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
S Bittner, SG Meuth, K Göbel, N Melzer, AM Herrmann, OJ Simon, A Weishaupt, T Budde, DA Bayliss, M Bendszus, H Wiendl |
Brain : a journal of neurology | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Voltage-gated potassium channels as therapeutic targets
H Wulff, NA Castle, LA Pardo |
Nature Reviews Drug Discovery | 2009 |
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes
MW Pennington, C Beeton, CA Galea, BJ Smith, V Chi, KP Monaghan, A Garcia, S Rangaraju, A Giuffrida, D Plank, G Crossley, D Nugent, I Khaytin, Y Lefievre, I Peshenko, C Dixon, S Chauhan, A Orzel, T Inoue, X Hu, RV Moore, RS Norton, KG Chandy |
Molecular pharmacology | 2009 |
The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy
P Bradding, H Wulff |
British Journal of Pharmacology | 2009 |
The functional network of ion channels in T lymphocytes
MD Cahalan, KG Chandy |
Immunological Reviews | 2009 |
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures
RP Lisak, JA Benjamins, B Bealmear, L Nedelkoska, D Studzinski, E Retland, B Yao, S Land |
Journal of Neuroinflammation | 2009 |
Blockade of T-Lymphocyte KCa3.1 and Kv1.3 Channels as Novel Immunosuppression Strategy to Prevent Kidney Allograft Rejection
I Grgic, H Wulff, I Eichler, C Flothmann, R Köhler, J Hoyer |
Transplantation Proceedings | 2009 |
Formulation-based approach to support early drug discovery and development efforts: a case study with enteric microencapsulation dosage form development for a triarylmethane derivative TRAM-34; a novel potential immunosuppressant
AM Al-Ghananeem, M Abbassi, S Shrestha, G Raman, H Wulff , L Pereira, A Ansari |
Drug Development and Industrial Pharmacy | 2009 |
The Class II Phosphatidylinositol 3 kinase C2β Is Required for the Activation of the K + Channel KCa3.1 and CD4 T-Cells
S Srivastava, L Di, O Zhdanova, Z Li, S Vardhana, Q Wan, Y Yan, R Varma, J Backer, H Wulff, ML Dustin, EY Skolnik, CH Heldin |
Molecular biology of the cell | 2009 |
Role of the Intermediate-conductance Calcium-activated Potassium Channels, KCa3.1, in Cellular Activation and Atherogenesis
Kazuyoshi Toyama, Heike Wulff, K. George Chandy, Philippe Azam, Girija Raman, Takashi Saito, Yoshimasa Fujiwara, David L. Mattson, Satarupa Das, James E. Melvin, Phillip F. Pratt, Ossama A. Hatoum, David D. Gutterman, David R. Harder, Hiroto Miura |
Journal of Clinical Investigation | 2008 |
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes
YR Ren, F Pan, S Parvez, A Fleig, CR Chong, J Xu, Y Dang, J Zhang, H Jiang, R Penner, JO Liu |
PloS one | 2008 |
K + Channel Modulators for the Treatment of Neurological Disorders and Autoimmune Diseases
H Wulff, BS Zhorov |
Chemical Reviews | 2008 |
Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block
MP Matheu, C Beeton, A Garcia, V Chi, S Rangaraju, O Safrina, K Monaghan, MI Uemura, D Li, S Pal, LM de la Maza, E Monuki, A Flügel, MW Pennington, I Parker, KG Chandy, MD Cahalan |
Immunity | 2008 |
4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3
SB Bodendiek, C Mahieux, W Hänsel, H Wulff |
European Journal of Medicinal Chemistry | 2008 |
Study of membrane potential in T lymphocytes subpopulations using flow cytometry
FM de Queiroz, CG Ponte, A Bonomo, R Vianna-Jorge, G Suarez-Kurtz |
BMC Immunology | 2008 |
Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis
P Azam, A Sankaranarayanan, D Homerick, S Griffey, H Wulff |
Journal of Investigative Dermatology | 2007 |
Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques
LE Pereira, F Villinger, H Wulff, A Sankaranarayanan, G Raman, AA Ansari |
Experimental biology and medicine (Maywood, N.J.) | 2007 |
Presence of HSV-1 Immediate Early Genes and Clonally Expanded T-cells with a Memory Effector Phenotype in Human Trigeminal Ganglia
T Derfuss, S Segerer, S Herberger, I Sinicina, K Hüfner, K Ebelt, HG Knaus, I Steiner, E Meinl, K Dornmair, V Arbusow, M Strupp, T Brandt, D Theil |
Brain Pathology | 2007 |
The Ca2+-Activated K+ Channel KCNN4/KCa3.1 Contributes to Microglia Activation and Nitric Oxide-Dependent Neurodegeneration
V Kaushal, PD Koeberle, Y Wang, LC Schlichter |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2007 |
Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.
Nicolaou SA, Szigligeti P, Neumeier L, Lee SM, Duncan HJ, Kant SK, Mongey AB, Filipovich AH, Conforti L |
Journal of immunology (Baltimore, Md. : 1950) | 2007 |
Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis.
Kasatkin DS, Spirin NN |
Neuroscience and Behavioral Physiology | 2007 |
Multiple sclerosis and headache co-morbidity. A case-control study.
Vacca G, Marano E, Brescia Morra V, Lanzillo R, De Vito M, Parente E, Orefice G |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2007 |
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, A Kolski-Andreaco, E Wei, A Grino, DR Counts, PH Wang, CJ LeeHealey, BS Andrews, A Sankaranarayanan, D Homerick, WW Roeck, J Tehranzadeh, KL Stanhope, P Zimin, PJ Havel, S Griffey, HG Knaus, GT Nepom, GA Gutman, PA Calabresi, KG Chandy |
Proceedings of the National Academy of Sciences | 2006 |
The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes
SA Nicolaou, L Neumeier, Y Peng, DC Devor, L Conforti |
American journal of physiology. Cell physiology | 2006 |
Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells
S Srivastava, K Ko, P Choudhury, Z Li, AK Johnson, V Nadkarni, D Unutmaz, WA Coetzee, EY Skolnik |
Molecular and cellular biology | 2006 |
Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases
C Beeton |
Molecular pharmacology | 2005 |
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain
H Rus, CA Pardo, L Hu, E Darrah, C Cudrici, T Niculescu, F Niculescu, KM Mullen, R Allie, L Guo, H Wulff, C Beeton, SI Judge, DA Kerr, HG Knaus, KG Chandy, PA Calabresi |
Proceedings of the National Academy of Sciences | 2005 |
Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels: Functional consequences of Kv1.3 channel inhibition during hypoxia in CD3 + cells
JR Robbins, SM Lee, AH Filipovich, P Szigligeti, L Neumeier, M Petrovic, L Conforti |
The Journal of Physiology | 2005 |
K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom
S Mouhat, V Visan, S Ananthakrishnan, H Wulff, N Andreotti, S Grissmer, H Darbon, MD Waard, JM Sabatier |
Biochemical Journal | 2004 |
K+ channels as targets for specific immunomodulation
KG Chandy, H Wulff, C Beeton, M Pennington, GA Gutman, MD Cahalan |
Trends in Pharmacological Sciences | 2004 |
Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells
G Panyi, G Vámosi, Z Bacsó, M Bagdány, A Bodnár, Z Varga, R Gáspár, L Mátyus, S Damjanovich |
Proceedings of the National Academy of Sciences | 2004 |